human plasminogen activator inhibitor 人pai
human plasminogen activator inhibitor 1 人纤溶酶原激活剂抑制物
human plasminogen-activator inhibitor type 人纤溶酶原激活物抑制物
recombinant human plasminogen activator inhibitor-1 型纤溶酶原激活物抑制剂
recombinant human tissue-type plasminogen activator 纤溶酶原激活剂
human tissue-type plasminogen activator mutant 人组织型纤溶酶原激活剂突变体
human tissue plasminogen activator 人组织纤溶酶原激活剂
human tissue plasminogen activator mutant 组织型纤溶酶原激活剂
Recombinant human urinary plasminogen activator 重组人糖基化尿型纤溶酶原激活剂
Urokinase, a human plasminogen activator, is used clinically to promote the dissolution of thrombi.
尿激酶是一种纤溶酶原激活剂，临床上用于治疗血栓。
Objective To investigate effects of two proinflammatory cytokines on the production of plasminogen activator inhibitor 1(PAI 1) by human pleural mesothelial cells(HPMC).
目的研究前炎症细胞因子对人胸膜间皮细胞（HPMC）释放纤溶酶原激活物抑制剂（PAI 1）的诱导效应。
The thrombolytic effect was compared between urokinase (UK) and human tissue plasminogen activator (t-PA) in rabbits with experimental iliofemoral artery thrombus.
本文用尿激酶(UK)和人体组织型纤溶酶原激活剂(t - PA)进行了兔髂股动脉血栓实验性溶解的对照研究。
应用推荐